“The Patent Trial and Appeal Board,” House Judiciary Committee Staff (Dem) (2022)
“APJ Day: Strategic Considerations for Advancing Your AIA Trial Position Through Conference Calls with the PTAB,” PTAB Bar Association Annual Conference, Washington, D.C. (2022)
“A View From the Bench – The Perspective of PTAB Judges,” Momentum Events 10th National Strategy Summit on Paragraph IV Litigation (2021)
“Legal Experience and Advancement Program,” AIPLA-PTAB Bench & Bar (2021)
“The APJs Speak on Practice, Policy and Procedure,” American Conference Institute 12th Summit on Biosimilars & Innovator Biologics (2021)
“Fast-Track Appeals Pilot Program,” PTAB Boardside Chat Webinar (2021)
“PTAB Stats and Substance: Questions and Controversies Surrounding Filings, Judicial Appointments, Standing and Expanded Powers,” American Conference Institute 14th Annual Paragraph IV Disputes (2020)
“PTAB Practice, Policy and Procedure,” American Conference Institute 11th Summit on Biosimilars & Innovator Biologics, (2020)
“Influential Women in IP,” World Intellectual Property Review (WIPR), Tysons Corner, VA (2019)
“PTAB: Hot Topics & The Intersection With District Court Litigation,” Delaware Chapter of the Federal Bar Association, Patent Trial & Appeal Board CLE, Wilmington, DE (2018)
“PTAB Practice and Impact of Recent Federal Circuit Decisions,” 12th Annual Advanced Patent Law Institute, Alexandria, VA (2017)
“Obviousness in PTAB Trials for Chem/Pharma/Bio Patents—How Strong Is Your Case?” World Intellectual Property Review (WIPR) (2016)
“Claim Definiteness,” 11th Annual Advanced Patent Law Institute, Alexandria, VA (2016)
“Exploring Inter-Partes Review and Covered Business Method Proceedings: IPR/CBM Procedures, Pitfalls and Strategies From Petition Through Appeal,” Los Angeles Intellectual Property Law Association (LAIPLA) “Washington in the West” Program (2016)
“Written Description & Enablement in Biotechnology & Pharmaceutical Cases,” USPTO-TIPO (Taiwan Intellectual Property Office) Examiner Exchange Program (2015)
“Claim Definiteness,” 10th Annual Advanced Patent Law Institute, Alexandria, VA (2015)
“Standard for Indefiniteness,” Bloomberg BNA Conference, Washington, D.C. (2014)
“Nautilus v. Biosig Instruments: Where Does the Definiteness Requirement Go From Here?” AIPLA Webinar (2014)
“A Discussion of Nautilus v. Biosig,” Federal Circuit Bar Association (FCBA) Webcast (2014)
“Written Description for Antibodies,” AIPLA Annual Meeting, Washington, D.C. (2012)
“The Written Description Requirement: Are Antibodies Chemicals, Proteins, or Exceptions?," American Bar Association (ABA) (2012)
